| Product dosage: 10mg | |||
|---|---|---|---|
| Package (num) | Per pill | Price | Buy |
| 30 | $2.21 | $66.27 (0%) | 🛒 Add to cart |
| 60 | $1.79 | $132.54 $107.44 (19%) | 🛒 Add to cart |
| 90 | $1.64 | $198.81 $147.60 (26%) | 🛒 Add to cart |
| 120 | $1.57 | $265.09 $188.77 (29%) | 🛒 Add to cart |
| 180 | $1.50 | $397.63 $270.11 (32%) | 🛒 Add to cart |
| 270 | $1.45
Best per pill | $596.44 $391.60 (34%) | 🛒 Add to cart |
Synonyms | |||
Similar products
More info:
rosuvastatin
Rosuvastatin represents one of the most potent synthetic statins available in clinical practice, specifically developed to address dyslipidemia through robust inhibition of HMG-CoA reductase. As a third-generation statin, it demonstrates significantly greater LDL cholesterol reduction per milligram compared to earlier agents like atorvastatin or simvastatin. What’s fascinating about rosuvastatin’s development was the deliberate molecular engineering to enhance hepatocyte selectivity while minimizing cytochrome P450 metabolism—this fundamentally different pharmacokinetic profile explains both its enhanced efficacy and potentially improved safety margin in appropriate patient populations.
atorlip 20
Product Description Atorlip 20 is a pharmaceutical formulation containing 20 mg of atorvastatin calcium per tablet, classified as a HMG-CoA reductase inhibitor (statin). It’s indicated for managing dyslipidemia - specifically to reduce elevated LDL cholesterol, apolipoprotein B, and triglyceride levels while increasing HDL cholesterol in patients with primary hypercholesterolemia, mixed dyslipidemia, or homozygous familial hypercholesterolemia. The tablets are film-coated, biconvex, and typically bear “ATORLIP” debossed on one side with “20” on the reverse.
biaxin
Biaxin, known generically as clarithromycin, is a macrolide antibiotic with a distinctive 14-membered lactone ring structure that’s been modified from erythromycin to enhance acid stability and tissue penetration. What’s fascinating clinically isn’t just its broad-spectrum coverage against respiratory pathogens, but how its unique metabolite, 14-hydroxy-clarithromycin, creates this synergistic antibacterial effect that’s particularly valuable in stubborn bronchitis cases. Key Components and Bioavailability of Biaxin The molecular structure contains a methoxy group at the 6-position - that’s the key modification that reduces acid degradation in the stomach compared to erythromycin.
Crestor: Potent LDL-C Reduction for Cardiovascular Risk Management - Evidence-Based Review
Crestor, known generically as rosuvastatin calcium, is a synthetic lipid-lowering agent belonging to the statin class of medications. It functions as a selective and competitive inhibitor of HMG-CoA reductase, the rate-limiting enzyme in the hepatic cholesterol biosynthesis pathway. In clinical practice, it’s a cornerstone therapy for managing dyslipidemia, specifically indicated to reduce elevated low-density lipoprotein cholesterol (LDL-C), increase high-density lipoprotein cholesterol (HDL-C), and slow the progression of atherosclerosis. Its development represented a significant advancement in achieving more aggressive LDL-C targets set by international guidelines.
diltiazem
Diltiazem hydrochloride represents one of the most versatile cardiovascular agents in our modern pharmacopeia, a calcium channel blocker with a fascinatingly specific electrophysiological profile that makes it particularly useful for rate control in atrial fibrillation while also providing robust antianginal effects. When I first started using diltiazem in the late 1990s, we primarily thought of it as just another calcium channel blocker, but over two decades of clinical application have revealed its unique niche in cardiovascular therapeutics that sets it apart from both dihydropyridines like amlodipine and non-dihydrophyridines like verapamil.
lipitor
Lipitor, known generically as atorvastatin calcium, represents one of the most widely prescribed and studied HMG-CoA reductase inhibitors in modern cardiovascular pharmacotherapy. Developed initially by Warner-Lambert and later by Pfizer, this synthetic statin has fundamentally reshaped lipid management protocols since its FDA approval in 1996. Unlike earlier natural statins derived from fungi, Lipitor’s fully synthetic structure allows for enhanced potency and predictable pharmacokinetics, making it a cornerstone therapy for atherosclerotic cardiovascular disease (ASCVD) risk reduction across diverse patient populations.
Lopid: Significant Triglyceride Reduction for Dyslipidemia - Evidence-Based Review
Gemfibrozil, marketed under the brand name Lopid, represents a significant class of lipid-modifying agents known as fibrates. This medication has been a cornerstone in managing specific dyslipidemias for decades, particularly when statins alone prove insufficient or are not tolerated. Its mechanism, distinct from other lipid-lowering drugs, targets peroxisome proliferator-activated receptor alpha (PPARα), leading to a profound reduction in triglyceride-rich very-low-density lipoproteins (VLDL) and a moderate increase in high-density lipoprotein (HDL) cholesterol.
Pravachol: Effective Cholesterol Management and Cardiovascular Risk Reduction - Evidence-Based Review
Pravastatin sodium, marketed under the brand name Pravachol, is an HMG-CoA reductase inhibitor—a statin medication—primarily indicated for managing dyslipidemia and preventing cardiovascular events. Unlike many dietary supplements, this is a prescription pharmaceutical with a robust, decades-long clinical history. I remember first encountering it during my cardiology rotation in the late 90s; we were just beginning to understand how powerfully these drugs could shift mortality curves in high-risk populations. 1. Introduction: What is Pravachol?
zocor
Simvastatin, marketed under the brand name Zocor, represents a cornerstone in the management of dyslipidemia and cardiovascular risk reduction. As an HMG-CoA reductase inhibitor, this medication has fundamentally altered the therapeutic landscape since its introduction, providing clinicians with a powerful tool to modify lipid profiles and, more importantly, improve hard cardiovascular outcomes. The story of Zocor extends beyond mere cholesterol numbers—it’s about preventing myocardial infarctions, strokes, and cardiovascular deaths through robust evidence-based medicine.